- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
EuropaBio Announces Finalists for Most Innovative European Biotech SME Awards 2017
EuropaBio, the European Association for Bioindustries, today announces the finalists for 8th edition of the Most Innovative European Biotech SME Awards, which recognizes innovative biotech SMEs and the crucial role they play in answering some of society’s greatest challenges.
Twenty-five small and medium biotech companies contended for this year’s awards, with five of them shortlisted by the Jury to compete across three categories: healthcare, industrial and agricultural biotechnology. They will be showcased during a pitching session, followed by an awards ceremony hosted by Awards Jury Member and MEP Paul Rubig at the European Parliament in Brussels, Belgium on November 22.
The five shortlisted SMEs are:
Healthcare/“Red Biotech” Category
Nightingale Health, a Finnish biotechnology company addressing chronic diseases with a proprietary blood analysis platform that can improve risk prediction of, among others, cardiovascular diseases and diabetes.
NovaBiotics, a UK-based clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases.
Industrial/“White Biotech” Category
Carbios, a French green chemistry company focused on discovering and developing enzymatic bioprocesses to reinvent the lifecycle of plastics.
Numaferm, a German spin-off company from the Institute of Biochemistry of the Heinrich-Heine-University in Düsseldorf that has developed a reliable, cost-efficient technology to manufacture peptides based on well-designed microorganisms that convert simple nutrients to peptides.
Agricultural/ “Green Biotech” Category
Iden Biotechnology, a Spanish company developing biotech products and integrated solutions for crop yield and quality enhancement, including agrobiological products (e.g. plant biostimulants and biopesticides), and more productive crop varieties.
Visit the awards website to read more about the awards, the jury and the rules.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
